Z-1509-2016 Class III Terminated
FDA device recall Z-1509-2016 was initiated by OraSure Technologies, Inc. on Jan 15, 2016 and is designated Class III. Reason for recall: OraSure Technologies, Inc. discovered the package insert included with the OraQuick HCV Rapid Antibody test Visual Reference Panel may be incorrect due to a complaint received from one of their… The recall status is terminated (terminated Feb 7, 2018). Affected quantity: 244 Visual Reference Panel Kits.
Recall details
- Product Type
- Devices
- Report Date
- Apr 27, 2016
- Initiation Date
- Jan 15, 2016
- Termination Date
- Feb 7, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 244 Visual Reference Panel Kits
Product description
OraQuick HCV Visual Reference Panel Intended to assist new operation in becoming proficient at reading specimens with antibody levels near the limit of detection of the device.
Reason for recall
OraSure Technologies, Inc. discovered the package insert included with the OraQuick HCV Rapid Antibody test Visual Reference Panel may be incorrect due to a complaint received from one of their customers. The customer reported they received the Ora Quick Ebola Visual Reference Panel instead of an OraQuick HCV Visual Reference Panel.
Distribution pattern
Nationwide Distribution -- AK, AL, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KY, LA, MA, MI, MO, MT, NC, ND, NE, NH, NM, NY, OH, OR, PA, RI, SC, SD, TN, TX, VA, WA, and WI.
Code information
Item Number 1001-0343, Lot # 6648737
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1509-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026